P. Tanghøj

868 total citations
18 papers, 653 citations indexed

About

P. Tanghøj is a scholar working on Pharmacology, Experimental and Cognitive Psychology and Psychiatry and Mental health. According to data from OpenAlex, P. Tanghøj has authored 18 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 6 papers in Experimental and Cognitive Psychology and 6 papers in Psychiatry and Mental health. Recurrent topics in P. Tanghøj's work include Treatment of Major Depression (8 papers), Schizophrenia research and treatment (6 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (5 papers). P. Tanghøj is often cited by papers focused on Treatment of Major Depression (8 papers), Schizophrenia research and treatment (6 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (5 papers). P. Tanghøj collaborates with scholars based in Denmark, United Kingdom and France. P. Tanghøj's co-authors include Stuart Montgomery, K. Fredricson Overø, J Rasmussen, Per Bech, Henning Friis Andersen, Dan J. Stein, Siegfried Kasper, Anders G. Pedersen, P. Cialdella and Patrice Rioux and has published in prestigious journals such as Psychopharmacology, Schizophrenia Research and Acta Psychiatrica Scandinavica.

In The Last Decade

P. Tanghøj

17 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Tanghøj Denmark 11 313 285 156 97 85 18 653
A. P. P. van Willigenburg Netherlands 6 246 0.8× 160 0.6× 213 1.4× 43 0.4× 22 0.3× 6 531
Alessandra Signoretti Italy 7 319 1.0× 306 1.1× 155 1.0× 100 1.0× 41 0.5× 9 730
Dennis Sweitzer United States 11 196 0.6× 672 2.4× 50 0.3× 142 1.5× 24 0.3× 13 833
Charles S. Wilcox United States 16 320 1.0× 275 1.0× 272 1.7× 171 1.8× 24 0.3× 27 806
P. Danjou France 11 60 0.2× 121 0.4× 118 0.8× 34 0.4× 13 0.2× 25 404
J Weissenburger France 7 117 0.4× 70 0.2× 83 0.5× 44 0.5× 85 1.0× 15 362
Meghan M. Grady United States 9 317 1.0× 334 1.2× 124 0.8× 94 1.0× 40 0.5× 16 808
Margaretta Nyilas United States 15 427 1.4× 1.2k 4.0× 108 0.7× 313 3.2× 28 0.3× 28 1.4k
Rajesh C. Shrotriya United States 12 128 0.4× 110 0.4× 151 1.0× 60 0.6× 16 0.2× 16 560
Vasilios G. Masdrakis Greece 14 142 0.5× 248 0.9× 137 0.9× 126 1.3× 46 0.5× 45 535

Countries citing papers authored by P. Tanghøj

Since Specialization
Citations

This map shows the geographic impact of P. Tanghøj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Tanghøj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Tanghøj more than expected).

Fields of papers citing papers by P. Tanghøj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Tanghøj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Tanghøj. The network helps show where P. Tanghøj may publish in the future.

Co-authorship network of co-authors of P. Tanghøj

This figure shows the co-authorship network connecting the top 25 collaborators of P. Tanghøj. A scholar is included among the top collaborators of P. Tanghøj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Tanghøj. P. Tanghøj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Thomas, Simon H. L., Milou D. Drici, Gillian C. Hall, et al.. (2010). Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP). Acta Psychiatrica Scandinavica. 122(5). 345–355. 45 indexed citations
3.
Bech, Per, P. Tanghøj, Kate Andreasson, & K. Fredricson Overø. (2010). Dose–response relationship of sertindole and haloperidol using the pharmacopsychometric triangle. Acta Psychiatrica Scandinavica. 123(2). 154–161. 4 indexed citations
4.
Crocq, M.A., Д. Набер, M Lader, et al.. (2010). Suicide attempts in a prospective cohort of patients with schizophrenia treated with sertindole or risperidone. European Neuropsychopharmacology. 20(12). 829–838. 19 indexed citations
5.
Bech, Per, P. Tanghøj, Kate Andreasson, & K. Fredricson Overø. (2010). SERTINDOLE AND HALOPERIDOL REVISITED; THE PSYCHOMETRIC TRIANGLE. Schizophrenia Research. 117(2-3). 259–259. 1 indexed citations
6.
Peuskens, Joseph, et al.. (2008). The Sertindole Cohort Prospective (SCoP) study: rationale, design and methodology. Pharmacoepidemiology and Drug Safety. 17(5). 425–433. 10 indexed citations
7.
Tanghøj, P., et al.. (2008). THE SERTINDOLE COHORT PROSPECTIVE (SCOP) STUDY: RATIONALE, DESIGN, AND METHODOLOGY. Schizophrenia Research. 102(1-3). 270–270.
8.
9.
Bech, Per, P. Tanghøj, P. Cialdella, Henning Friis Andersen, & Anders G. Pedersen. (2004). Escitalopram dose–response revisited: an alternative psychometric approach to evaluate clinical effects of escitalopram compared to citalopram and placebo in patients with major depression. The International Journal of Neuropsychopharmacology. 7(3). 283–290. 61 indexed citations
10.
11.
Bech, Per, P. Tanghøj, Henning Friis Andersen, & K. Fredricson Overø. (2002). Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression. Psychopharmacology. 163(1). 20–25. 73 indexed citations
12.
Stein, Dan J., Stuart Montgomery, Siegfried Kasper, & P. Tanghøj. (2001). Predictors of response to pharmacotherapy with citalopram in obsessive-compulsive disorder. International Clinical Psychopharmacology. 16(6). 357–361. 50 indexed citations
13.
Overø, K. Fredricson, et al.. (1999). Cardiac Safety of Citalopram: Prospective Trials and Retrospective Analyses. Journal of Clinical Psychopharmacology. 19(5). 407–415. 76 indexed citations
14.
Montgomery, Stuart, et al.. (1994). The optimal dosing regimen for citalopram-a meta-analysis of nine placebo-controlled studies. International Clinical Psychopharmacology. 9. 35–40. 55 indexed citations
15.
Montgomery, Stuart, J Rasmussen, & P. Tanghøj. (1993). A 24-week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depression. International Clinical Psychopharmacology. 8(3). 181–188. 130 indexed citations
16.
Rasmussen, J., S.A. Montgomery, Lisbeth V. Jacobsen, & P. Tanghøj. (1993). Dose and profile of citalopram in the management of depressive illness. European Neuropsychopharmacology. 3(3). 325–326. 1 indexed citations
17.
Christophersen, J, Torkil Menné, P. Tanghøj, et al.. (1989). Clinical patch test data evaluated by multivariate analysis. Contact Dermatitis. 21(5). 291–299. 71 indexed citations
18.
Christophersen, J, Torkil Menné, P. Tanghøj, et al.. (1989). Impact of individual factors on clinical patch test results with special reference to age.. PubMed. 8(2). 127–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. P. P. van Willigenburg Breakdown of academic impact, for papers by Alessandra Signoretti Breakdown of academic impact, for papers by Dennis Sweitzer Breakdown of academic impact, for papers by Charles S. Wilcox Breakdown of academic impact, for papers by P. Danjou Breakdown of academic impact, for papers by J Weissenburger Breakdown of academic impact, for papers by Meghan M. Grady Breakdown of academic impact, for papers by Margaretta Nyilas Breakdown of academic impact, for papers by Rajesh C. Shrotriya Breakdown of academic impact, for papers by Vasilios G. Masdrakis
Rankless by CCL
2026